Quotes Cerevel Therapeutics Holdings, Inc.
Stocks
CERE
US15678U1280
Biotechnology & Medical Research
|
Delayed
Nasdaq
00:00:00 01/08/2024 +04
|
5-day change | 1st Jan Change | ||
| 44.96 USD | +0.74% |
|
-.--% | - |
Stock exchange
Nasdaq
CERE 44.96 $
+0.74%
679M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | +0.74% | ||
| 3 years | +114.71% | ||
| 5 years | +91.65% |
Volumes
marketsDaily volume
15,096,384
Estimated daily volume
19,213,281
Record volume 1
85,962,450
Record volume 2
31,256,341
Record volume 3
15,096,384
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
8,191,474,701
Net sales ()
-
Number of employees
355
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
93.64 %
Free-Float capitalization (USD)
7,670,416,311
Indicators
Moving average 5 days
44.66
Moving average 100 days
41.9
Price spread / (MMA5)
-0.68%
Price spread / (MMA100)
-6.81%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.74% | -.--% | -.--% | +114.71% | 8.19B | ||
| -1.90% | +2.37% | +69.11% | +110.88% | 73.45B | ||
| +0.87% | +15.32% | +56.99% | +92.41% | 62.99B | ||
| +0.44% | -2.59% | +1.29% | +485.68% | 28.05B | ||
| -1.40% | +4.18% | +54.52% | +19.60% | 25.42B | ||
| +20.16% | +19.36% | -0.64% | -5.82% | 23.3B | ||
| +2.28% | +5.65% | +42.00% | -13.75% | 19.45B | ||
| 0.00% | -4.11% | +243.99% | +423.83% | 18.16B | ||
| -3.50% | -0.95% | +17.17% | +534.55% | 16.53B | ||
| +2.36% | +7.96% | +44.96% | +154.52% | 13.16B | ||
| Average | +2.00% | +2.47% | +52.94% | +191.66% | 28.87B | |
| Weighted average by Cap. | +1.32% | +4.26% | +56.10% | +163.46% |
Historical Quotes: Cerevel Therapeutics Holdings, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 3 years | 19.59 | 44.99 | |
| 5 years | 19.59 | 46.16 | |
| 10 years | 9 | 46.16 |
Monthly variations
Annual variations
| 2024 | +6.04% | ||
| 2023 | +34.43% | ||
| 2022 | -2.71% | ||
| 2021 | +95.54% | ||
| 2020 | +39.33% |
- Stock Market
- Stocks
- CERE Stock
- Quotes Cerevel Therapeutics Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
















